Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Walsh

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
BMJ Open|December 25, 2025
Effectiveness of etrasimod on disease activity and patient-reported outcomes in ulcerative colitis-EFFECT-UC: a non-interventional, multinational, prospective cohort study protocolGordon W Moran, Shellie J Radford, Alissa Walsh, et al.
Scandinavian Journal of Gastroenterology|November 9, 2020
Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel diseaseKrupa Krishnaprasad, Alissa Walsh, Jakob Begun, et al.
Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.
The American Journal of Gastroenterology|November 26, 2025
Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare ProvidersMarla Dubinsky, Alison Potts Bleakman, Stephan Vavricka, et al.
Frontline Gastroenterology|October 17, 2022
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort studySailish Honap, Lulia Al-Hillawi, Samantha Baillie, et al.
Journal of Crohn'S & Colitis|June 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 studyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
United European Gastroenterology Journal|June 3, 2026
Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European CountriesStefan Schreiber, Alissa Walsh, Peter Hur, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2006
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosisAlissa Walsh, Jeannette L Dixon, Grant A Ramm, et al.
Journal of Crohn'S & Colitis|June 7, 2020
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis HistopathologyFernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|June 12, 2023
Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMsLawrence Matini, Thomas P Chapman, Ramona Kantschuster, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
BMJ Open|December 25, 2025
Effectiveness of etrasimod on disease activity and patient-reported outcomes in ulcerative colitis-EFFECT-UC: a non-interventional, multinational, prospective cohort study protocolGordon W Moran, Shellie J Radford, Alissa Walsh, et al.
Scandinavian Journal of Gastroenterology|November 9, 2020
Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel diseaseKrupa Krishnaprasad, Alissa Walsh, Jakob Begun, et al.
Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.
The American Journal of Gastroenterology|November 26, 2025
Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare ProvidersMarla Dubinsky, Alison Potts Bleakman, Stephan Vavricka, et al.
Frontline Gastroenterology|October 17, 2022
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort studySailish Honap, Lulia Al-Hillawi, Samantha Baillie, et al.
Journal of Crohn'S & Colitis|June 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 studyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
United European Gastroenterology Journal|June 3, 2026
Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European CountriesStefan Schreiber, Alissa Walsh, Peter Hur, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2006
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosisAlissa Walsh, Jeannette L Dixon, Grant A Ramm, et al.
Journal of Crohn'S & Colitis|June 7, 2020
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis HistopathologyFernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|June 12, 2023
Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMsLawrence Matini, Thomas P Chapman, Ramona Kantschuster, et al.
Pageof 4